Other news to note for Nov. 24, 2025 Nov. 24, 2025 Biopharma happenings, including deals and partnerships, and other news in brief: Actimed, Anaptysbio, GSK, Lava, Tesaro, Xoma.Read More
In the clinic for Nov. 24, 2025 Nov. 24, 2025 Clinical updates, including data readouts and publications: Blue Lake, Contineum.Read More
Financings for Nov. 24, 2025 Nov. 24, 2025 Biopharmas raising money in public or private financings, including: Bioatla, Inhibikase.Read More
Appointments and advancements for Nov. 24, 2025 Nov. 24, 2025 New hires and promotions in the biopharma industry, including: Edgewise, Novabridge, Visara, Vivac.Read More
New Samyang Holdings, Samsung Biologics spin-offs debut on Kospi Nov. 24, 2025 By Marian (YoonJee) Chu No Comments Two South Korean conglomerates – Samyang Holdings Corp. and Samsung Biologics Co. Ltd. – listed their newly spun-off biopharmaceutical units on Korea Exchange’s (KRX) main trading board Nov. 24.Read More
Novo’s semaglutide fails in phase III Alzheimer’s trials Nov. 24, 2025 No Comments A preview of the next edition of BioWorld, Nov. 24, 2025Read More
Biggest gainers and losers for Nov. 17-21, 2025 Nov. 24, 2025 The top 10 biopharma stock gainers and losers for the week.Read More
Biopharma money raised: Jan. 1-Nov. 20, 2025 Nov. 21, 2025 Year-to-date money raised in public, private and other financings of biopharma companies.Read More
Money raised by biopharma Nov. 21, 2025 Total raised in public, private and other financings of biopharma companies, comparing 2019-2025.Read More
RSS
